• About us
    • About us
    • Team
    • Board of director
    • Strategic advisory board
    • Scientific advisory board
    • Patient Advisory Board
    • Investors
    • Partners
  • Products
    • MailPan®
    • ExOlin®
  • Indications
    • Diabetes
    • Hemophilia A
    • Glioblastoma
    • Peritoneal metastasis
  • Innovation
    • iNanoBIT
    • DECAPES
  • Media & Rewards
  • News
  • Contact
  • EN
    • FR
Defymed Logo
  • About us
    • About us
    • Team
    • Board of director
    • Strategic advisory board
    • Scientific advisory board
    • Patient Advisory Board
    • Investors
    • Partners
  • Products
    • MailPan®
    • ExOlin®
  • Indications
    • Diabetes
    • Hemophilia A
    • Glioblastoma
    • Peritoneal metastasis
  • Innovation
    • iNanoBIT
    • DECAPES
  • Media & Rewards
  • News
  • Contact
  • EN
    • FR

  • Aurélien Lathuilière

    Home Aurélien Lathuilière Aurélien Lathuilière

  • Recent posts

    • Defymed at ATTD 2023
    • Defymed at the annual conference of the European Society for Biomaterials (ESB)
    • 02 June 2022: Séverine Sigrist joins the French team of Women Leaders
Defymed Logo

Offices

  • 9 rue Calmette
    67200 Strasbourg
    France
  • + 33 (0)3 90 41 04 46

Laboratories

  • Centre Européen Étude du Diabète C.E.E.D.
    Boulevard René Leriche
    67200 Strasbourg
    France
  • + 33 (0)3 90 41 04 46
Contact us

Follow us :

All rights reserved Defymed 2023.

Privacy policy Legal notices Cookies
Defymed Adeliom Adeliom Agency